Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin (Q39436754)

12 September 2017

title

Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin (English)

1 reference

12 September 2017

main subject

squamous cell carcinoma

1 reference

Matt Williams

1

1 reference

12 September 2017

Angela Swampillai

2

1 reference

12 September 2017

Melanie Osborne

3

1 reference

12 September 2017

Suzannah Mawdsley

4

1 reference

12 September 2017

Rob Hughes

5

1 reference

12 September 2017

Mark Harrison

6

1 reference

12 September 2017

Richard Harvey

7

1 reference

12 September 2017

Rob Glynne-Jones

8

1 reference

12 September 2017

Mount Vernon Colorectal Cancer Network

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

10 April 2013

1 reference

12 September 2017

1 reference

12 September 2017

volume

119

1 reference

12 September 2017

issue

13

1 reference

12 September 2017

page(s)

2391-2398

1 reference

12 September 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Carcinoma of the anal canal, a clinical and pathologic study of 188 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Sentinel Node Biopsy in Squamous-Cell Carcinoma of the Anal Canal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Assessment of "squamous cell carcinoma antigen" (SCC) as a marker of epidermoid carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Reporting recommendations for tumor marker prognostic studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

ACT II: the second UK phase III anal cancer trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Prospective Evaluation of Squamous Cell Carcinoma and Carcinoembryonic Antigen as Prognostic Factors in Patients with Cervical Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Squamous Cell Carcinoma Antigen in Follow-Up of Cervical Cancer Treated With Radiotherapy: Evaluation of Cost-Effectiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Squamous cell carcinoma antigen in patients with cancer of the larynx

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Squamous cell carcinoma of the anus at one hospital from 1948 to 1984

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28055

7 January 2021

Identifiers

DOI

10.1002/CNCR.28055

1 reference

12 September 2017

1 reference